期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Is sarcopenia effective on survival in patients with metastatic gastric cancer?
1
作者 ozlem dogan Hayriye Sahinli +2 位作者 Yakup Duzkopru Tuba Akdag Abdulkadir Kocanoglu 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第5期1861-1868,共8页
BACKGROUND Sarcopenia is a progressively diminishing state characterized by the reduction of muscle mass and density,which is frequently observed in malignancies of solid organs.AIM To assess how sarcopenia affects th... BACKGROUND Sarcopenia is a progressively diminishing state characterized by the reduction of muscle mass and density,which is frequently observed in malignancies of solid organs.AIM To assess how sarcopenia affects the overall survival of individuals who have been diagnosed with metastatic gastric cancer.METHODS The study retrospectively included individuals who had been diagnosed with metastatic gastric cancer between January 2008 and December 2020.Sarcopenia was identified through the calculation of the average Hounsfield units(HUAC)using computed tomography(CT)images taken at the time of diagnosis in patients.RESULTS A total of 118 patients with metastatic gastric cancer were evaluated.Sarcopenia was detected in 29 patients(24.6%).The median survival of all patients was 8(1-43)mo.The median survival of patients with sarcopenia was 2 mo,while it was 10 mo for those without sarcopenia(P<0.001).A significant relationship was found between sarcopenia and survival.CONCLUSION Sarcopenia has been observed to impact survival outcomes in various types of solid tumor cancers.Sarcopenic patients can be identified in a short time,easily and inexpensively,by HUAC measurements from CT images used for diagnosis,and survival could be promoted with nutritional support. 展开更多
关键词 Hounsfield units SARCOPENIA Gastric cancer SURVIVAL Psoas muscle mass Muscle density
下载PDF
Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer 被引量:3
2
作者 Yakup Duzkopru Abdulkadir Kocanoglu +3 位作者 ozlem dogan Hayriye Sahinli Ebru Cilbir Mustafa Altinbas 《World Journal of Gastrointestinal Oncology》 SCIE 2023年第9期1626-1635,共10页
BACKGROUND The hemoglobin,albumin,lymphocyte,and platelet(HALP)score,derived from a composite evaluation of markers reflecting the tumor-inflammation relationship and nutritional status,has been substantiated as a not... BACKGROUND The hemoglobin,albumin,lymphocyte,and platelet(HALP)score,derived from a composite evaluation of markers reflecting the tumor-inflammation relationship and nutritional status,has been substantiated as a noteworthy prognostic determinant for diverse malignancies.AIM To investigate how the HALP score relates to prognosis in patients with metastatic gastric cancer.METHODS The cutoff values for the HALP score,neutrophil/lymphocyte ratio,and platelet/lymphocyte ratio were determined using receiver operating characteristic analysis.Low HALP scores were defined as those less than 24.79 and high HALP scores as those greater than 24.79.RESULTS The study cohort comprised 147 patients and 110 of them(74.8%)were male.The patients'median age was 63(22-89)years.The median overall survival was significantly superior in the patients with high HALP scores than in those with low HALP scores(10.4 mo vs 7.5 mo,respectively;P<0.001)CONCLUSION The HALP score was found to be a prognostic factor in patients with metastatic gastric cancer. 展开更多
关键词 Biomarker Hemoglobin albumin lymphocyte and platelet score Gastric cancer Nutritional index PROGNOSIS Survival
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部